COLL — Collegium Pharmaceutical, Inc. stock price, charts and financials

QT39Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
27.20
-2.27-7.70%
OverviewShort InterestFilings
COLLQT39Collegium Pharmaceutical, Inc.·NASDAQ
27.20-7.70%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Aug 05, 2026SC 13GBeneficial ownership statement (passive)
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jun 30, 20268-K/ACurrent report (amended)
Jun 10, 20264Statement of changes in beneficial ownership
Jun 01, 2026S-8Registration of employee benefit securities
Jun 01, 2026S-8Registration of employee benefit securities
May 20, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 2026144Notice of proposed sale of restricted securities
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20263Initial statement of beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 20264Statement of changes in beneficial ownership
May 15, 20268-KCurrent report
May 15, 2026144Notice of proposed sale of restricted securities
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 2026144Notice of proposed sale of restricted securities
#1 / 25 of 381
Page
▼
/ 16